Skip to main content
logo
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.495
+0.015 (0.33%)
At close: Sep 22, 2026, 4:00 PM EDT
4.500
+0.005 (0.11%)
After-hours: Sep 22, 2026, 7:30 PM EDT

Lifecore Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 May '25 May '24 May '23 May '22
Market Capitalization
170306249172241291
Market Cap Growth
-42.20%23.18%44.93%-28.69%-17.27%-17.12%
Enterprise Value
296472419305395424
Last Close Price
4.508.186.725.627.949.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 May '25 May '24 May '23 May '22
PE Ratio
---14.29--
Forward PE
-8.178.1725.55167.00250.59
PS Ratio
1.312.371.931.342.332.62
PB Ratio
5.009.005.253.196.863.31
P/TBV Ratio
-----4.17
P/FCF Ratio
27.3149.20----
P/OCF Ratio
13.5424.39-667.99--
PEG Ratio
-25.0625.0625.0625.0625.06

EV Ratios

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 May '25 May '24 May '23 May '22
EV/Sales Ratio
2.293.653.252.373.823.81
EV/EBITDA Ratio
35.9657.32-123.49-29.82
EV/FCF Ratio
47.5875.84----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 May '25 May '24 May '23 May '22
Debt / Equity Ratio
4.224.222.762.393.211.71
Debt / EBITDA Ratio
16.8316.83-43.34-9.63
Debt / FCF Ratio
23.0723.07----
Net Debt / Equity Ratio
3.713.712.582.232.671.70
Net Debt / EBITDA Ratio
15.3215.32-30.8048.73-13.2810.49
Net Debt / FCF Ratio
20.2720.27-9.00-6.62-2.40-2.84
Asset Turnover
--0.520.510.390.29
Inventory Turnover
--2.452.141.961.46
Quick Ratio
2.182.181.461.021.230.22
Current Ratio
3.493.492.842.092.390.66
Return on Equity (ROE)
---76.41%20.97%-104.52%-10.65%
Return on Assets (ROA)
---3.04%-1.35%-4.67%-0.55%
Return on Invested Capital (ROIC)
-0.76%-0.76%-6.98%-3.56%-10.79%-1.05%
Return on Capital Employed (ROCE)
-0.60%-0.60%-5.70%-2.60%-9.20%-3.50%

Yields

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 May '25 May '24 May '23 May '22
Earnings Yield
-20.28%-10.05%-15.56%7.00%-41.36%-40.11%
FCF Yield
3.66%2.03%-5.47%-10.56%-16.17%-18.05%
Buyback Yield / Dilution
-1.63%-7.33%5.02%-22.36%-1.67%-0.59%
SEC Filings: 10-K · 10-Q